Surgical treatment for idiopathic rhinitis using nerve procedures
Official title: Assessment of the Effectiveness and Safety of Posterior Nasal Nerve Combined With Anterior Ethmoid Neurotomy in Patients With Idiopathic Rhinitis: a Prospective, Multicentre, Parallel-controlled Study
Run by Renmin Hospital of Wuhan University · NCT06870292 · Data updated 2026-11-12
This study tests if a new type of surgery can help people with idiopathic rhinitis feel better than just using regular medication.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | Renmin Hospital of Wuhan University Academic / other |
| Locations | 2 sites (Wuhan, Hubei and 1 other locations) |
| Status | Recruiting |
| Started | October 1, 2026 |
| Main results expected | October 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | September 24, 2026 |
| Trial ID | NCT06870292 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are nonsmoking adults aged 18 to 65 with a diagnosis of idiopathic rhinitis and specific symptom criteria.
✕Probably not a fit
Patients with other forms of chronic rhinitis or nasal conditions such as polyps or chronic sinusitis may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effectiveness of a surgical approach combining posterior nasal nerve neurotomy with anterior ethmoid neurotomy for patients suffering from idiopathic rhinitis. Participants are randomized into two groups: one receiving the surgical intervention and the other receiving conventional drug therapy. The study includes a 7-day introductory period with nasal spray treatment before randomization, followed by a one-year follow-up to assess outcomes. The goal is to determine if the surgical method provides better relief from symptoms compared to medication alone.
Why it matters
Potential benefit: If successful, this approach could offer a more effective long-term solution for patients with idiopathic rhinitis who do not respond well to medication.
How similar studies have gone: While similar surgical approaches have been explored, this specific combination of techniques for idiopathic rhinitis is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients signed the free and informed consent form and understood the explanation of the study. 2. patients with IR between 18 and 65 years and their body mass index (BMI) should be ≥19 kg/m2 and ≤24 kg/m2. 3. Patients diagnosed with idiopathic rhinitis (IR)that were defined as nonsmoking patients with at least 2 nasal complaints of nasal obstruction, rhinorrhea, itching, and/or sneezing for more than 1 hour a day and for more than 1 year. 4. Patients with negative skin prick test (SPT) responses or sIgE 5. Nasal cytological exam with eosinophilia less than 20%. 6. Patients had a Total Nasal Symptom Score (TNSS) of ≥6 and a subscore of nasal discharge ≥2 and a subscore of nasal congestion ≥1. Exclusion Criteria: 1. Patients with colored secretions, inflammation,nasal polyps, chronic sinusitis, nasal tumours. 2. Patients with other chronic rhinitis such as occupational rhinitis, drug rhinitis, gustatory rhinitis, hormonal rhinitis, atrophic rhinitis, etc. 3. Patients with anatomic nasal abnormalities responsible for nasal symptoms. 4. Patients with nasal/sinus surgery 3 months before the study. 5. Patients with severe mental illness. 6. Patients with uncontrolled asthma, systemic disorders or malignancies. 7. Patients with history of chronic smoking, substance abuse, drug use, and/or excessive alcohol consumption. 8. Patients in pregnancy or lactation.
Where it's running
-
Renmin Hospital of Wuhan University
Wuhan, Hubei, China Recruiting -
Renmin Hospital of Wuhan University
Wuhan, Hubei, China Not yet recruiting
Study contacts
- Study coordinator: Yu Xu
- Email: xuy@whu.edu.cn
- Phone: +8615927088198
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ivarmacitinib with Camrelizumab and Fruquintinib in advanced colorectal cancer after prior therapies
This trial tests whether combining ivarmacitinib with camrelizumab and fruquintinib can help patients with metastatic colorectal cancer who have progressed after multiple treatments.
-
Low-intensity ultrasound to calm the nerves and improve sleep after heart surgery
This trial tests whether gentle, focused ultrasound on the left stellate ganglion can improve autonomic function and sleep after heart-related surgery in adults with cardiovascular disease, compared with a sham treatment.
-
Ultrasound treatment to calm neck nerves after a heart attack to stop dangerous rhythms
This trial tests whether low-intensity focused ultrasound to the left Stellate ganglion can reduce ventricular arrhythmias after a STEMI treated with PCI.
-
Giving heparin before arrival for people with STEMI who will have primary PCI.
This trial will test whether giving an IV loading dose of unfractionated heparin before hospital arrival helps adults with STEMI who are going for primary PCI.
-
Digital out-of-hospital care for people with early cardiogenic shock
This trial tests whether the HeartMed-HF digital out-of-hospital management program can reduce one-year deaths and unplanned hospital readmissions in adults with early cardiogenic shock.
-
AI-assisted diagnosis of colorectal tubular adenomas using white-light, magnifying chromoendoscopy (including NBI) and pathology images
This project will test whether an AI tool that combines white-light, magnified chromoendoscopy, NBI, and pathology images can help doctors identify colorectal tubular adenomas in adults undergoing colonoscopy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.